|
JP5295785B2
(ja)
|
2006-02-20 |
2013-09-18 |
エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション |
細胞膜透過性ペプチド
|
|
KR101169030B1
(ko)
*
|
2009-01-21 |
2012-07-26 |
애니젠 주식회사 |
신규한 세포막 투과 도메인 및 이를 포함하는 세포내 전달 시스템
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2857499A1
(en)
|
2010-10-01 |
2015-04-08 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
PT3682905T
(pt)
|
2011-10-03 |
2022-04-07 |
Modernatx Inc |
Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
|
|
ES2923757T3
(es)
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
CN104507961B
(zh)
|
2012-05-11 |
2018-08-14 |
珍白斯凯尔有限公司 |
抗炎性肽及包含其的组合物
|
|
EP2875826B1
(en)
|
2012-05-11 |
2017-08-23 |
KAEL-GemVax Co.,Ltd |
Composition for preventing or treating sepsis
|
|
WO2014010971A1
(ko)
*
|
2012-07-11 |
2014-01-16 |
주식회사 카엘젬백스 |
세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
|
|
EP2899201B1
(en)
|
2012-09-19 |
2019-09-11 |
Gemvax & Kael Co., Ltd. |
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
|
|
EP2899199B1
(en)
|
2012-09-19 |
2019-07-03 |
Gemvax & Kael Co., Ltd. |
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
|
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
|
KR101495417B1
(ko)
*
|
2013-01-31 |
2015-02-26 |
이화여자대학교 산학협력단 |
인슐린 점막 투과 개선용 조성물
|
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
KR101595152B1
(ko)
*
|
2013-04-10 |
2016-02-17 |
이화여자대학교 산학협력단 |
Tctp-ptd를 포함하는 유전자 전달체
|
|
KR102258864B1
(ko)
|
2013-04-19 |
2021-06-01 |
주식회사 젬백스앤카엘 |
허혈성 손상 치료 및 예방용 조성물
|
|
KR101491016B1
(ko)
*
|
2013-05-31 |
2015-02-10 |
건국대학교 산학협력단 |
배반포 및 생식기관 암 세포 특이적인 단백질 운반 방법 및 그 조성물
|
|
AU2014275610B2
(en)
|
2013-06-07 |
2018-06-14 |
Gemvax & Kael Co., Ltd. |
Biological markers useful in cancer immunotherapy
|
|
ES2808076T3
(es)
|
2013-06-21 |
2021-02-25 |
Gemvax & Kael Co Ltd |
Regulador de la secreción hormonal, composición que lo contiene y procedimiento para controlar la secreción hormonal mediante su uso
|
|
CA2923029A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
ES2773296T3
(es)
|
2013-10-23 |
2020-07-10 |
Gemvax & Kael Co Ltd |
Composición para tratar y prevenir la hiperplasia prostática benigna
|
|
GB201318954D0
(en)
*
|
2013-10-28 |
2013-12-11 |
Cupid Peptide Company Ltd |
Cell transport
|
|
KR102359396B1
(ko)
|
2013-11-22 |
2022-02-08 |
주식회사 젬백스앤카엘 |
혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
|
|
KR20210133323A
(ko)
|
2013-12-13 |
2021-11-05 |
바스프 에스이 |
정밀 화학물질의 개선된 생산을 위한 재조합 미생물
|
|
JP6367950B2
(ja)
|
2013-12-17 |
2018-08-01 |
ジェムバックス アンド カエル カンパニー,リミティド |
前立腺癌治療用組成物
|
|
ES2908096T3
(es)
|
2014-04-11 |
2022-04-27 |
Gemvax & Kael Co Ltd |
Péptido con actividad inhibidora de la fibrosis y composición que lo contiene
|
|
WO2015167067A1
(ko)
|
2014-04-30 |
2015-11-05 |
주식회사 카엘젬백스 |
장기, 조직 또는 세포 이식용 조성물, 키트 및 이식 방법
|
|
PT3149025T
(pt)
*
|
2014-05-21 |
2019-08-01 |
Entrada Therapeutics Inc |
Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
|
|
EP3156063B1
(en)
*
|
2014-06-16 |
2019-12-25 |
Ewha University-Industry Collaboration Foundation |
Binding inhibitor between tctp dimer type ige-dependent histamine releasing factor and receptor thereof, and use thereof
|
|
EP3171895A1
(en)
|
2014-07-23 |
2017-05-31 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
KR102413243B1
(ko)
|
2014-12-23 |
2022-06-27 |
주식회사 젬백스앤카엘 |
안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
|
|
US10835582B2
(en)
|
2015-02-27 |
2020-11-17 |
Gemvax & Kael Co. Ltd. |
Peptide for preventing hearing loss, and composition comprising same
|
|
EP3305802B1
(en)
|
2015-05-26 |
2021-05-12 |
Gemvax & Kael Co., Ltd. |
Anti-inflammatory, anti-fibrotic and wound-healing octapeptides and compositions containing the same
|
|
JP6923453B2
(ja)
|
2015-07-02 |
2021-08-18 |
ジェムバックス アンド カエル カンパニー,リミティド |
抗ウイルス活性効能を有するペプチド及びこれを含む組成物
|
|
CN108350030B
(zh)
*
|
2015-09-10 |
2022-12-13 |
汉阳大学校产学协力团 |
皮肤可渗透肽及其使用方法
|
|
US10688153B2
(en)
|
2015-11-06 |
2020-06-23 |
The Board Of Trustees Of The University Of Illinois |
Peptides and method for treatment of cardiac arrest
|
|
JP7341451B2
(ja)
|
2016-02-01 |
2023-09-11 |
エピアクシス セラピューティクス プロプライアタリー リミティド |
タンパク質性化合物とその利用
|
|
WO2017176076A1
(en)
|
2016-04-06 |
2017-10-12 |
Ewha University - Industry Collaboration Foundation |
A peptide with ability to penetrate cell membrane
|
|
JP6795679B2
(ja)
*
|
2016-04-06 |
2020-12-02 |
アイキュア ビーエヌピー カンパニー リミテッド |
細胞膜に浸透する能力を有するペプチド
|
|
ES2949697T3
(es)
|
2016-04-07 |
2023-10-02 |
Gemvax & Kael Co Ltd |
Péptido que tiene efectos de aumento de la actividad telomerasa y de extensión de los telómeros, y composición que contienen el mismo
|
|
AU2017375828B2
(en)
*
|
2016-12-16 |
2021-04-15 |
Avixgen Inc |
Cytoplasmic transduction peptide and intracellular messenger comprising same
|
|
AU2018270111B2
(en)
|
2017-05-18 |
2022-07-14 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
|
|
EP4253544A3
(en)
|
2017-05-18 |
2023-12-20 |
ModernaTX, Inc. |
Modified messenger rna comprising functional rna elements
|
|
EP3638292A1
(en)
|
2017-06-14 |
2020-04-22 |
ModernaTX, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
PE20200697A1
(es)
|
2017-06-22 |
2020-06-16 |
Catalyst Biosciences Inc |
Polipeptidos de serina proteasa 1 de tipo membrana modificada (mtsp-1) y metodos de uso
|
|
CA3109871A1
(en)
|
2017-08-22 |
2019-02-28 |
Monash University |
Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (rage)
|
|
CN111587120A
(zh)
|
2017-11-08 |
2020-08-25 |
艾比克斯治疗私人有限公司 |
免疫原性组合物及其用途
|
|
EP3714048B1
(en)
|
2017-11-22 |
2025-04-09 |
ModernaTX, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
|
JP7424976B2
(ja)
|
2017-11-22 |
2024-01-30 |
モダーナティエックス・インコーポレイテッド |
プロピオン酸血症の治療用のプロピオニルCoAカルボキシラーゼアルファ及びベータサブユニットをコードするポリヌクレオチド
|
|
US11939601B2
(en)
|
2017-11-22 |
2024-03-26 |
Modernatx, Inc. |
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
|
|
KR101933217B1
(ko)
|
2017-12-28 |
2018-12-27 |
(주) 에빅스젠 |
피부 염증 억제용 펩티드 및 이를 포함하는 피부 염증 예방 또는 치료용 조성물
|
|
US11802146B2
(en)
|
2018-01-05 |
2023-10-31 |
Modernatx, Inc. |
Polynucleotides encoding anti-chikungunya virus antibodies
|
|
WO2019165183A1
(en)
|
2018-02-22 |
2019-08-29 |
Entrada Therapeutics, Inc. |
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
|
|
WO2019217682A1
(en)
|
2018-05-09 |
2019-11-14 |
Ohio State Innovation Foundation |
Cyclic cell-penetrating peptides with one or more hydrophobic residues
|
|
MA52709A
(fr)
|
2018-05-23 |
2021-03-31 |
Modernatx Inc |
Administration d'adn
|
|
WO2020023390A1
(en)
|
2018-07-25 |
2020-01-30 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
US10842827B2
(en)
*
|
2018-08-22 |
2020-11-24 |
José Manuel Aguilar Yáñez |
Treatment and compound for epithelial wounds
|
|
MA53545A
(fr)
|
2018-09-02 |
2021-07-14 |
Modernatx Inc |
Polynucléotides codant pour l'acyl-coa déshydrogénase à très longue chaîne pour le traitement de l'insuffisance en acyl-coa déshydrogénase à très longue chaîne
|
|
JP2022500436A
(ja)
|
2018-09-13 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
糖原病を処置するためのグルコース−6−ホスファターゼをコードするポリヌクレオチド
|
|
US12644102B2
(en)
|
2018-09-13 |
2026-06-02 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex E1-α, E1-β, and E2 subunits for the treatment of maple syrup urine disease
|
|
MA53615A
(fr)
|
2018-09-14 |
2021-07-21 |
Modernatx Inc |
Polynucléotides codant pour le polypeptide a1, de la famille de l'uridine diphosphate glycosyltransférase 1, pour le traitement du syndrome de crigler-najjar
|
|
WO2020069169A1
(en)
|
2018-09-27 |
2020-04-02 |
Modernatx, Inc. |
Polynucleotides encoding arginase 1 for the treatment of arginase deficiency
|
|
JP7604376B2
(ja)
|
2018-12-28 |
2024-12-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
改変ウロキナーゼ型プラスミノゲンアクティベータポリペプチドおよび使用方法
|
|
MA55082A
(fr)
|
2019-03-01 |
2022-01-05 |
Flagship Pioneering Innovations Vi Llc |
Compositions, procédés, et kits pour l'administration de polyribonucléotides
|
|
KR102901623B1
(ko)
|
2019-03-01 |
2025-12-18 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
폴리리보뉴클레오티드 및 이의 미용적 용도
|
|
WO2020227642A1
(en)
|
2019-05-08 |
2020-11-12 |
Modernatx, Inc. |
Compositions for skin and wounds and methods of use thereof
|
|
CN112694522B
(zh)
*
|
2020-03-11 |
2022-06-14 |
浙江大学 |
一种基于GluN2A亚基的细胞穿膜肽及其应用
|
|
KR102274999B1
(ko)
*
|
2020-04-23 |
2021-07-08 |
주식회사 아임뉴런바이오사이언스 |
신규한 세포 투과성 펩타이드 및 이의 용도
|
|
IL298363A
(en)
|
2020-05-20 |
2023-01-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and uses thereof
|
|
AU2021285812A1
(en)
|
2020-06-01 |
2023-01-05 |
Modernatx, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
|
IL300947A
(en)
|
2020-09-03 |
2023-04-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and uses thereof
|
|
CA3199784A1
(en)
|
2020-11-13 |
2022-05-19 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
KR20220085522A
(ko)
*
|
2020-12-15 |
2022-06-22 |
주식회사 아이큐어비앤피 |
세포막 투과성을 갖는 신규 펩타이드
|
|
US20240207374A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
|
WO2022204369A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
|
WO2022204380A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
|
US20240189449A1
(en)
|
2021-03-24 |
2024-06-13 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
|
WO2022204390A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
|
KR20220157778A
(ko)
*
|
2021-05-21 |
2022-11-29 |
원큐어젠 주식회사 |
세포 투과성 펩타이드 및 글루카곤 유사 펩타이드-1 수용체 작용제를 포함하는 복합체
|
|
US20240384277A1
(en)
|
2021-06-15 |
2024-11-21 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
|
US20240376445A1
(en)
|
2021-06-22 |
2024-11-14 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
US20250017867A1
(en)
|
2021-10-01 |
2025-01-16 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
US20250282819A1
(en)
*
|
2021-10-13 |
2025-09-11 |
Camp Therapeutics Inc. |
Mitochondria-specific peptide that can be intracellularly delivered at nanomolar concentration, and use thereof
|
|
KR20230061895A
(ko)
*
|
2021-10-29 |
2023-05-09 |
주식회사 아이큐어비앤피 |
지질 나노입자 및 세포 투과성을 갖는 신규 펩타이드의 복합체
|
|
WO2023183909A2
(en)
|
2022-03-25 |
2023-09-28 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
|
EP4562163A1
(en)
|
2022-07-26 |
2025-06-04 |
ModernaTX, Inc. |
Engineered polynucleotides for temporal control of expression
|
|
WO2024117321A1
(ko)
*
|
2022-12-01 |
2024-06-06 |
㈜에빅스젠 |
세포막 투과 펩티드 및 이를 포함하는 세포내 전달체
|
|
WO2024197033A1
(en)
|
2023-03-21 |
2024-09-26 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of heart failure
|
|
EP4704816A1
(en)
|
2023-05-03 |
2026-03-11 |
ModernaTX, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2025009503A1
(ja)
*
|
2023-07-03 |
2025-01-09 |
メスキュージェナシス株式会社 |
細胞膜透過性を有するペプチドおよびそのスクリーニング方法
|
|
WO2025072482A1
(en)
|
2023-09-27 |
2025-04-03 |
Modernatx, Inc. |
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof
|
|
WO2025255199A1
(en)
|
2024-06-05 |
2025-12-11 |
Modernatx, Inc. |
Argininosuccinate synthase 1 and argininosuccinate lyase polypeptides and polynucleotides and uses thereof
|
|
WO2026152164A1
(en)
|
2025-01-13 |
2026-07-16 |
Sail Biomedicines, Inc. |
Cd5-targeted lipid nanoparticles encapsulating polyribonucleotides encoding chimeric antigen receptors, and methods to generate car-expressing t cells in vivo
|